SCHEMBL16237208

SCHEMBL16237208

Cc1[nH]c(C(=O)Nc2ccc(F)c(C#N)c2)cc1S(=O)(=O)Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRM4 Q14833 2/20 0.50
▸ LRRK2 Q5S007 1/20 0.42
▸ PLA2G7 Q13093 3/20 0.38
▸ BLM P54132 1/20 0.37
▸ WRN Q14191 1/20 0.37
▸ NPC1 O15118 3/20 0.37
▸ RAB9A P51151 3/20 0.37
▸ MAPT P10636 1/20 0.37
▸ THRB P10828 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ AKT1 P31749 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ PRNP P04156 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ RXFP1 Q9HBX9 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ KCNQ3 O43525 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16237501 0.86 RAB9A (0.48) PLA2G7NPC1RAB9AMAPTTHRB
SCHEMBL16236610 0.85 NPC1 (0.49) PLA2G7NPC1RAB9AMAPTTHRB
SCHEMBL16237029 0.82 CYP1A2 (0.41) PLA2G7NPC1RAB9AMAPTTHRB
SCHEMBL16237067 0.81 GRM4 (0.41) GRM4PLA2G7NPC1RAB9AMAPT
SCHEMBL16237311 0.80 GRM4 (0.49) GRM4NPC1RAB9AMAPTMAPK1
SCHEMBL16237050 0.79 PLA2G7 (0.37) PLA2G7
SCHEMBL16237215 0.79 CYP1A2 (0.45) PLA2G7NPC1RAB9AKDM4EALDH1A1
SCHEMBL16236529 0.79 IDO1 (0.43) GRM4NPC1RAB9AMAPK1AKT1
SCHEMBL21623094 0.78 GRM4 (0.55) GRM4MAPTMAPK1ALDH1A1MEN1
SCHEMBL16236925 0.76 CYP1A2 (0.36) PLA2G7NPC1RAB9AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2997011-A1 SULPHAMOYLPYRROLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B Janssen Sciences Ireland UC (IE) 2016-03-23 — — EP disclosed
WO-2014184350-A1 SULPHAMOYLPYRROLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B JANSSEN R&D IRELAND (IE) 2014-11-20 — — WO disclosed
Send feedback